Xiangyang Wang (Jihong Wang)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

mAbs

Antibodies (Basel, Switzerland)

Biotechnology and bioengineering

Viela Bio

Rutgers University New Brunswick (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Viela Bio Sep 04 2019

United States

Director :: Analytical Sciences

AstraZeneca Aug 23 2004 - Sep 03 2019

United States

Principal Scientist :: Analytical Sceinces

Education History

Rutgers University New Brunswick Aug 26 1992 - Oct 25 1997

United States

PHD :: Chemistry

University of Science and Technology of China Sep 01 1983 - Jul 08 1988

China

BSC :: Chemistry

Publications

Jing Zhen, Jennifer Lee, Yueyang Wang, Lena McLaughlin, Fei Yang, Zheng-Jian Li, Xiangyang Wang
Characterization of N-Terminal Asparagine Deamidation and Clipping of a Monoclonal Antibody. Antibodies (Basel, Switzerland) 12 (3) (2023)
Weimin Chen, Madhu Pandey, Hong Sun, Andrea Rolong, Mingyan Cao, Dengfeng Liu, Xiangyang Wang, Lingmin Zeng, Alan Hunter, Shihua Lin
Development of a mechanism of action-reflective, dual target cell-based reporter bioassay for a bispecific monoclonal antibody targeting human CTLA-4 and PD-1. mAbs 13 (1) (2022)
Jun Kim, Yoen Joo Kim, Mingyan Cao, Niluka De Mel, Methal Albarghouthi, Kenneth Miller, Jared S Bee, Jihong Wang, Xiangyang Wang
Analytical characterization of coformulated antibodies as combination therapy. mAbs 12 (1) (2021)
Gargi Roy, Jason Reier, Andrew Garcia, Tom Martin, Megan Rice, Xiangyang Wang, Meagan Prophet, Ronald Christie, William Dall'Acqua, Sanjeev Ahuja, Michael A Bowen, Marcello Marelli
Development of a high yielding expression platform for the introduction of non-natural amino acids in protein sequences. mAbs 12 (1) (2021)
Michael W Handlogten, Xiangyang Wang, Sanjeev Ahuja
Online control of cell culture redox potential prevents antibody interchain disulfide bond reduction. Biotechnology and bioengineering 117 (5) (2020)
Claire Harris, Weichen Xu, Luigi Grassi, Chunlei Wang, Abigail Markle, Colin Hardman, Richard Stevens, Guillermo Miro-Quesada, Diane Hatton, Xiangyang Wang
Identification and characterization of an IgG sequence variant with an 11 kDa heavy chain C-terminal extension using a combination of mass spectrometry and high-throughput sequencing analysis. mAbs 11 (8) (2019)
Mingyan Cao, Niluka De Mel, Anthony Shannon, Meagan Prophet, Chunlei Wang, Weichen Xu, Ben Niu, Jun Kim, Methal Albarghouthi, Dengfeng Liu, Eric Meinke, Shihua Lin, Xiangyang Wang, Xiangyang Wang
Charge variants characterization and release assay development for co-formulated antibodies as a combination therapy. mAbs 11 (3) (2019)

Xiangyang Wang.css-eqlu8i{font-size:small;padding-left:4px;} (Jihong Wang)

Publication Activity (10 Years)

Top Topics

Top Venues

Xiangyang Wang (Jihong Wang)